Paraguay | Imports and Exports | World | Pharmaceutical products | Value (US$) and Value Growth, YoY (%) | 2012 - 2023
The value of exports of commodity group 30 "Pharmaceutical products" from Paraguay totalled $ 73 million in 2023. Sales of commodity group 30 from Paraguay went up by 1.54% compared to 2022: exports of commodity group 30 "Pharmaceutical products" went up by $ 1.12 million (cumulative exports of commodity group 30 from Paraguay amounted $72 million in 2022)
Exports of commodity group 30 "Pharmaceutical products" amounted to 0.619% of total exports from Paraguay (cumulative merchandise exports from Paraguay totalled $ 11.8 billion in 2023). The share of commodity group 30 in total exports from Paraguay decreased by 0.109 p.p. compared to 2022 (it was 0.729% in 2022 and cumulative exports from Paraguay were equal to $ 9.94 billion).
Where does Paraguay export Pharmaceutical products?
Top export destinations of "Pharmaceutical products" from Paraguay in 2023:
- Bolivia with a share of 14.2% (10.5 million US$)
- Ecuador with a share of 13.5% (9.96 million US$)
- Peru with a share of 12.4% (9.2 million US$)
- Uruguay with a share of 9.15% (6.74 million US$)
- Brazil with a share of 8.01% (5.9 million US$)
- Colombia with a share of 7.01% (5.17 million US$)
- Panama with a share of 6.71% (4.94 million US$)
- Mexico with a share of 5.53% (4.07 million US$)
- Chile with a share of 4.26% (3.14 million US$)
- France with a share of 3.64% (2.68 million US$)
Exports structure of 30 - Pharmaceutical products - from Paraguay in 2023 represented by the following main commodity groups:
- 84% (61 million US$): 3004 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale
- 14.4% (10.6 million US$): 3002 - Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc
- 1.04% (773 thousand US$): 3005 - Wadding, gauze, bandages and similar articles (for example, dressings, adhesive plasters, poultices), impregnated or coated with pharmaceutical substances or put up in forms or packings for retail sale for medical, surgical, dental or veterinary purposes.
- 0.364% (268 thousand US$): 3006 - Pharmaceutical goods specified in Note 4 to this Chapter.
- 0.035% (26 thousand US$): 3001 - Glands, organs (extracts, secretions thereof) for organo-therapeutic uses, dried, powdered or not; heparin and its salts; other human or animal substances for therapeutic or prophylactic uses n.e.s.
- 0.001% (1.22 thousand US$): 3003 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale
The value of imports of commodity group 30 "Pharmaceutical products" to Paraguay totalled $ 485 million in 2023. Sales of commodity group 30 to Paraguay went up by 12.4% compared to 2022: imports of commodity group 30 "Pharmaceutical products" went up by $ 53 million (the value of imports of commodity group 30 to Paraguay was equal to $431 million in 2022)
Imports of commodity group 30 "Pharmaceutical products" accounted for 3.01% of total import flow to Paraguay (in 2023, total imports to Paraguay amounted to $ 16.1 billion). The share of commodity group 30 in total imports to Paraguay increased by 0.296 p.p. compared to 2022 (it was 2.72% in 2022 and cumulative imports to Paraguay were equal to $ 15.8 billion).
Where does Paraguay import Pharmaceutical products from?
Top trading partners (import of "Pharmaceutical products") of Paraguay in 2023:
- Germany with a share of 16.7% (81 million US$)
- USA with a share of 16.2% (78 million US$)
- Argentina with a share of 12.8% (62 million US$)
- Brazil with a share of 7.1% (34 million US$)
- Switzerland with a share of 5.35% (26 million US$)
- France with a share of 4.96% (24 million US$)
- Ireland with a share of 4.89% (23 million US$)
- Chile with a share of 4.08% (19.8 million US$)
- India with a share of 3.33% (16.2 million US$)
- Belgium with a share of 3.06% (14.9 million US$)
Imports structure of 30 - Pharmaceutical products - to Paraguay in 2023 represented by the following main commodity groups:
- 49% (240 million US$): 3002 - Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc
- 45% (223 million US$): 3004 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale
- 2.32% (11.3 million US$): 3006 - Pharmaceutical goods specified in Note 4 to this Chapter.
- 0.995% (4.83 million US$): 3003 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale
- 0.987% (4.79 million US$): 3005 - Wadding, gauze, bandages and similar articles (for example, dressings, adhesive plasters, poultices), impregnated or coated with pharmaceutical substances or put up in forms or packings for retail sale for medical, surgical, dental or veterinary purposes.
- 0.169% (824 thousand US$): 3001 - Glands, organs (extracts, secretions thereof) for organo-therapeutic uses, dried, powdered or not; heparin and its salts; other human or animal substances for therapeutic or prophylactic uses n.e.s.
